# Imatinib Mesylate

NDC: 59651-240
Generic name: Imatinib Mesylate
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20200723

FDA application: ANDA212773

## Active ingredients

- IMATINIB MESYLATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-240"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-240
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4e409f7-20b4-4c80-8a6a-f95995ffad78